Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality
If EVLP technology is available, under certain circumstances, surgeons should not be dissuaded from using an allograft with extended ischemic time.
Authors
- Nahush A. Mokadam (ORCID: https://orcid.org/0000-0001-7189-5997)
- Doug A. Gouchoe (ORCID: https://orcid.org/0000-0002-3177-4637)
- Bryan A. Whitson (ORCID: https://orcid.org/0000-0003-0040-3638)
- Matthew C. Henn (ORCID: https://orcid.org/0000-0002-1561-7009)
- Asvin M. Ganapathi (ORCID: https://orcid.org/0000-0003-2765-3733)
- Kukbin Choi (ORCID: https://orcid.org/0000-0003-2982-5164)
- David R. Nunley (ORCID: https://orcid.org/0000-0002-3409-4127)
- Divyaam Satija (ORCID: https://orcid.org/0009-0006-1838-6564)
- Ahmed Aly (ORCID: https://orcid.org/0000-0002-1050-3205)
- Ervin Y. Cui
Institutions
- The Ohio State University Wexner Medical Center (US)
Publication Details
- Journal
- Artificial Organs
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1111/aor.14820
- Citations
- 2
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Health Resources and Services Administration